Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2010.0132
EDITORIAL
|
Trastuzumab for small HER2-positive breast cancer? Uncertainty and new research directions
|
|
Affiliation: 2nd Surgical Department, Aristotle University of Thessaloniki , "G, Gennimatas" General Hospital , Thessaloniki , Greece .
Tel
+302310992567,
Email:
imakris@auth.gr |
Since there is no abstract available we provide the first paragraph
Although cure is achievable in small breast cancer, a subgroup of women faces a recurrence risk. This article discusses advances and limitations in predicting this high-risk group, whether trastuzumab for small, HER2-positive tumors can reduce recurrence risk. New research directions including cancer stem cells and molecular networks are also described.
(Citation: Gastric & Breast Cancer 2010; 9(3): 106-109)
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €33 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
Online
ISSN : 1109 - 7647
Print ISSN : 1109 - 7655
 We
subscribe to the HONcode principles. Verify
here.
please, read our policy about privacy
and confidentiality of information and transparency
of sponsorship
|
